University of Salamanca
Also known as: Aymara Abreu Corrales | Centro Asistencial Universitario de Salamanca (CAUSA) | Complejo Universitario de Salamanca | Fundación General de la Universidad de Salamanca | Guzmán Franch Arcas - C. A. U. Salamanca | Hospital Clinico de Salamanca | Hospital Clinico de Salamanca, Spain | Hospital Clinic of Salamanca | Hospital Clinico Universitario de Salamanca | Hospital Clínico Universitario de Salamanca | Hospital de Salamanca | Hospital Unisversitario de Salamanca | Hospital Universitario de Salamanca | Hospital Universitario de Salamanca (Salamanca) | Hospital Universitario de Salamanca, Salamanca. Spain. | Hospital Universitario Salamanca | IBSAL-Instituto de Investigación Biomédica de Salamanca | IBSAL-Instituto de Investigación Biomédica de Salamanca, Fundación IECSCYL-IBSAL | IBSAL - University Hospital of Salamanca | Instituto de Investigación Biomédica de Salamanca | Salamanca University | Universitario de Salamanca | University Clinical Hospital of Salamanca | University of Salamanca | University of Salamanca, Faculty of Medicine
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2003Last known activity
Oct 31, 2025
Timeline
1250s
- Jun 1, 1255
University of Salamanca— Founded
Drugs by trial phase (75 distinct, 57 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (46 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Aggression
- Anemia
- Anus Neoplasms
- Aortic Valve Stenosis
- Carcinoma
- Carcinoma, Squamous Cell
- Constriction, Pathologic
- Delirium
- Graft vs Host Disease
- Graves Disease
- Head and Neck Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis, Viral, Human
- Hodgkin Disease
- Hyperthyroidism
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukopenia
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Osteoarthritis
- Osteoarthritis, Knee
- Preleukemia
- Prostatic Neoplasms
- Recurrence
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Spondylitis
- Spondylitis, Ankylosing
- Syndrome
- Thrombocytopenia
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT07107529OfficialPhase 2Oct 31, 2025
- NCT07195331OfficialPhase 4Oct 15, 2025
- NCT07195331Lead sponsorPhase 4Oct 15, 2025
- NCT06905834Lead sponsorPhase 2Jun 30, 2025
- NCT07045909OfficialPhase 2Jun 30, 2025
- NCT06905834OfficialPhase 2Jun 30, 2025
- NCT07254754OfficialPhase 2Nov 20, 2024
- NCT06906315Sponsor investigatorPhase 4Nov 4, 2024
- NCT06906315OfficialPhase 4Nov 4, 2024
- NCT06906315Lead sponsorPhase 4Nov 4, 2024
- NCT06243458OfficialPhase 2Sep 10, 2024
- NCT06243458CollaboratorPhase 2Sep 10, 2024
- NCT05849610Study chairPhase 2Nov 30, 2023
- NCT06282978OfficialPhase 2Nov 23, 2023
- NCT05558319Study chairPhase 3Oct 31, 2022
Details
- Founded
- Salamanca, ES Jun 1, 1255
- Last known activity
- Oct 31, 2025